Priyanka Biswas

Priyanka Biswas

Auto-generated profile, based on publicly available information

Priyanka Biswas

Department of Life Sciences, Imperial College London, London, UK

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2025 in Gut Microbes
Verified
Journal Article
Open access
PBPriyanka Biswas
Priyanka Biswas
JSJulia Sanchez-Garrido
Julia Sanchez-Garrido
ZKZuzanna Kozik
Zuzanna Kozik
VMVishwas Mishra
Vishwas Mishra
DRDavid Ruano-Gallego
David Ruano-Gallego
GFGad Frankel
Gad Frankel
Injection of effectors via a type III secretion system (T3SS) is an infection strategy shared by various Gram-negative bacterial pathogens, many infecting mucosal surfaces. While individual T3SS effectors are well characterized, their network-level organization and the distinction between core and accessory effectors remain incompletely understood. Here, by systematically dissecting the T3SS effector network of the enteric mouse pathogen Citrobacter rodentium (CR) we identified a subset of 12 accessory effectors that, while dispensable for colonization, significantly alter infection outcomes. A strain lacking the accessory effectors (CRM12) remained virulent in susceptible mouse hosts yet resulted in reduced epithelial barrier damage, inflammation, and immune cell infiltration in resistant mice. Deep proteomic analysis specifically targeting CR-attached colonic epithelial cells revealed that, despite lacking 39% of its effector repertoire, infection with CRM12 results in similar changes to global protein expression as seen in mice infected with the wild-type strain, though key regulators of barrier integrity were differentially expressed. Using a host with impaired barrier repair (Il22- /- mice), we confirmed that accessory effectors collectively shape infection outcomes without significantly impacting virulence. This study refines the concept of core and accessory effectors, providing a basis for further studies into effector-driven host adaptation.

23 February 2017 in Journal of Evolution of Medical and Dental Sciences
Verified
Journal Article
Open access
MMMahadeo Mandal
Mahadeo Mandal
SDSangeeta Dey
Sangeeta Dey
DKDhananjay Kumar
Dhananjay Kumar
PBPriyanka Paul Biswas
Priyanka Paul Biswas
KNKrishan Nandan
Krishan Nandan
ASAninda Sen
Aninda Sen

8 December 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
VMVishwas Mishra
Vishwas Mishra
ZKZuza Kozik
Zuza Kozik
PBPriyanka Biswas
Priyanka Biswas
JCJyoti Choudhary
Jyoti Choudhary
JWJoshua L. C. Wong
Joshua L. C. Wong
GFGad Frankel
Gad Frankel
Interleukin-22 (IL-22) is considered indispensable for host defence against Citrobacter rodentium , with 100% mortality of Il22 −/− mice. While IL-22 promotes epithelial barrier integrity and production of antimicrobial peptides, the precise mechanism underlying lethality remains unclear. Here, we show that following C. rodentium infection Il22 −/− mice succumb due to dehydration, rather than failure to control bacterial burden or regenerate damaged intestinal epithelium. Proteomic and gene expression analysis reveal greater enterocyte depletion in C. rodentium -infected Il22 −/− mice, resulting in significant reductions in ion transporter abundances. We show that while not reducing bacterial load, improving the gut barrier integrity, or affecting immune responses, fluid therapy (FT) fully rescues Il22 −/− mice by correcting systemic dehydration. Survival is associated with locally increased Reg3b , IL-17F and IL-10 levels, suggesting activation of compensatory pathways that potentially support recovery in the absence of IL-22. Recovered Il22 −/− mice exhibit epithelial cell regeneration and tissue physiology similarly to C. rodentium -infected Il22 +/+ mice. These findings suggest that dehydration is the primary cause of mortality in Il22 −/− mice and reveal that IL-22 prevent this outcome by preserving epithelial integrity and fluid-ion absorption. Importantly, this study underscores the necessity of incorporating supportive therapies into preclinical infection models to better reflect physiological settings and improve their relevance in modelling human disease.

9 June 2026 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
DBDaniel J Bennison
Daniel J Bennison
ICIshaan Chaudhary
Ishaan Chaudhary
DCDharitri Chaudhuri
Dharitri Chaudhuri
JWJustin Chun Ngai Wong
Justin Chun Ngai Wong
APAyush Punwatkar
Ayush Punwatkar
ASAvinash R Shenoy
Avinash R Shenoy
The IFNγ-induced GTPase guanylate-binding protein 1 (GBP1) binds to lipopolysaccharide (LPS) on cytosolic gram-negative bacteria and promotes pyroptosis via the recruitment and activation of caspase-4 on the bacterial outer membrane. Enteropathogenic and enterohaemorrhagic Escherichia coli (EPEC and EHEC, respectively) are extracellular pathogens that adhere to host cells and stimulate dense actin polymerisation underneath their attachment sites, generating structures described as actin-rich pedestals. Here, we show that GBP1 traffics to actin-rich pedestals in human cells infected with EPEC or EHEC in vitro and mouse colonocytes infected with the EPEC-like murine pathogen Citrobacter rodentium in vivo. GBP1 promotes caspase-4 recruitment to actin-rich pedestals, leading to pyroptosis and IL-18 release. GBP1 mutants defective in LPS coatomer formation also localise to EPEC pedestals. A novel assay that mimics pathogenic effector activity reveals GBP1 recruitment to sterile actin polymerisation sites. We conclude that cytosolic GBP1 is mobilised to sites of pathogen-induced actin remodelling independently of LPS. Our study establishes that GBP1 not only operates as a pattern-recognition receptor but also orchestrates effector-triggered immunity against pathogens that hijack the actin cytoskeleton.

10 March 2025 in Research Square
Verified
Preprint
Open access
PDF file
GFGad Frankel
Gad Frankel
VMVishwas Mishra
Vishwas Mishra
PBPriyanka Biswas
Priyanka Biswas
JWJoshua Wong
Joshua Wong
ZKZuza Kozik
Zuza Kozik
JCJyoti Choudhary
Jyoti Choudhary
Interleukin-22 (IL-22) is considered indispensable for host defence against Citrobacter rodentium (CR), with 100% mortality of Il22 −/− mice post infection. While IL-22 promotes epithelial barrier integrity and antimicrobial peptide production, the precise mechanism underlying Il22 −/− lethality remains unclear. Here, we show that Il22 −/− mice succumb to CR infection due to dehydration rather than uncontrolled bacterial burden or inability to regenerate intestinal epithelium. Proteomic analysis at 9 days post infection (dpi) revealed significant downregulation of ion transporters (Slc26a3, Aqp8, Ca2, Ca4, Slc5a8, Slc15a1) in Il22 −/− colonic epithelial cells, suggesting an association between IL-22 deficiency and impaired fluid-electrolyte balance. Fluid therapy (FT), initiated at 5 dpi and lasted for 2 weeks, fully rescued Il22 −/− mice, restoring survival without affecting bacterial burden, immune responses, or epithelial integrity. Recovered Il22 −/− mice exhibited epithelial regeneration and protection against reinfection, demonstrating that IL-22-independent pathways support long-term mucosal recovery. These findings overturn the long-standing paradigm that IL-22 is indispensable for host survival from CR infection, revealing that dehydration is the primary cause of mortality. Importantly, this study underscores the necessity of incorporating supportive therapies into preclinical infection models to better reflect physiological conditions and enhance translational relevance.

2 March 2020 in Journal of Evolution of Medical and Dental Sciences
Verified
Journal Article
Open access
ASAnupama Singh
Anupama Singh
PBPriyanka Paul Biswas
Priyanka Paul Biswas
ASAninda Sen
Aninda Sen